BACKGROUNDS: Adiponectin, adipocyte-fatty acid binding protein (A-FABP), and Wnt1 inducible signaling pathway protein-1 (WISP-1) are adipokines closely associated with insulin resistance. The aim of the study was to compare their levels in women with gestational diabetes (GDM), type 2 diabetes mellitus (T2DM) and healthy controls and determine their relation to metabolic parameters. METHODS: Women with GDM, T2DM and healthy women were included in this cross-sectional study. In addition to adipokines, anthropometric, lipid parameters, markers of insulin resistance and glucose control were assessed in all participants. RESULTS: Compared to healthy controls (n = 35) significantly lower levels of adiponectin were detected in women with GDM (n = 50), whereas in women with T2DM (n = 50) higher levels of A-FABP and WISP-1 and lower levels of adiponectin were found. Women with T2DM had also lower levels of adiponectin and higher levels of A-FABP compared to women with GDM. A-FABP and adiponectin were independently associated with levels of triglycerides, HDL-cholesterol and C-peptide insulin resistance index. WISP-1 correlated only with waist circumference. CONCLUSIONS: Adverse adipokines production reflecting dysfunctional fat tissue is less presented in women with GDM than in women with T2DM, but more expressed compared to healthy women.

University Hospital and Palacky University Faculty of Medicine and Dentistry 3rd Department of Internal Medicine Nephrology Rheumatology and Endocrinology Olomouc Czech Republic

Zobrazit více v PubMed

Bao W, Baecker A, Song Y, Kiely M, Liu S, Zhang C (2015). Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: A systematic review. Metabolism 64: 756-764. DOI: 10.1016/j.metabol.2015.01.013. PubMed DOI

Barchetta I, Cimini FA, Capoccia D, De Gioannis R, Porzia A, Mainiero F, et al. (2017). WISP1 Is a Marker of Systemic and Adipose Tissue Inflammation in Dysmetabolic Subjects With or Without Type 2 Diabetes. J Endocr Soc 1: 660-670. DOI: 10.1210/js.2017-00108. PubMed DOI

Christou GA, Kiortsis DN (2013). Adiponectin and lipoprotein metabolism. Obes Rev 14: 939-949. DOI: 10.1111/obr.12064. PubMed DOI

Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects (2008). The World Medical Association, Inc. [online] [cit. 2020-05-07]. Available at: https://www.wma.net/wp-content/uploads/2016/11/DoH-Oct2008.pdf

Furuhashi M (2019). Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases. J Atheroscler Thromb 26: 216-232. DOI: 10.5551/jat.48710. PubMed DOI

Furuhashi M, Saitoh S, Shimamoto K, Miura T (2015). Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases. Clin Med Insights Cardiol 8(Suppl. 3): 23-33. DOI: 10.4137/CMC.S17067. PubMed DOI

Gu L, Chen N, Li Z, Zhang F, Wang X (2019). Relationship of serum Wnt1-inducible signaling pathway protein 1 levels with coronary artery disease and its severity. Coron Artery Dis 30(7): 542-546. DOI: 10.1097/MCA.0000000000000745. PubMed DOI

Herrera E, Ortega-Senovilla H (2010). Disturbances in lipid metabolism in diabetic pregnancy - Are these the cause of the problem? Best Pract Res Clin Endocrinol Metab 24: 515-525. DOI: 10.1016/j.beem.2010.05.006. PubMed DOI

Hörbelt T, Tacke C, Markova M, Herzfeld de Wiza D, Van de Velde F, Bekaert M, et al. (2018). The novel adipokine WISP1 associates with insulin resistance and impairs insulin action in human myotubes and mouse hepatocytes. Diabetologia 61: 2054-2065. DOI: 10.1007/s00125-018-4636-9. PubMed DOI

Iliodromiti S, Sassarini J, Kelsey TW, Lindsay RS, Sattar N, Nelson SM (2016). Accuracy of circulating adiponectin for predicting gestational diabetes: a systematic review and meta-analysis. Diabetologia 59: 692-699. DOI: 10.1007/s00125-015-3855-6. PubMed DOI

Jin J, Peng DQ, Yuan SG, Zhao SP, Ning XH, Wang SH, Li SL (2010). Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio. Clin Chim Acta 411: 1761-1765. DOI: 10.1016/j.cca.2010.07.031. PubMed DOI

Kim JD, Kang SJ, Lee MK, Park SE, Rhee EJ, Park CY, et al. (2016). C-Peptide-Based Index Is More Related to Incident Type 2 Diabetes in Non-Diabetic Subjects than Insulin-Based Index. Endocrinol Metab (Seoul) 31: 320-327. DOI: 10.3803/EnM.2016.31.2.320. PubMed DOI

Kralisch S, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, et al. (2009). Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol 160: 33-38. DOI: 10.1530/EJE-08-0540. PubMed DOI

Lekva T, Michelsen AE, Aukrust P, Henriksen T, Bollerslev J, Ueland T (2017). Leptin and adiponectin as predictors of cardiovascular risk after gestational diabetes mellitus. Cardiovasc Diabetol 16: 5. DOI: 10.1186/s12933-016-0492-4. PubMed DOI

Li YY, Xiao R, Li CP, Huangfu J, Mao JF (2015). Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus. Med Sci Monit 21: 426-431. DOI: 10.12659/MSM.892431. PubMed DOI

Mazaki-Tovi S, Kanety H, Pariente C, Hemi R, Wiser A, Schiff E, Sivan E (2007). Maternal serum adiponectin levels during human pregnancy. J Perinatol 27: 77-81. DOI: 10.1038/sj.jp.7211639. PubMed DOI

Metzger BE, Gabbe SG, Persson B, Buchanan TA, Lowe LP, Dyer AR, et al. (2010). International association of diabetes and pregnancy study groups recommendations on the diagnosis and classificationof hyperglycemia in pregnancy. Diabetes Care 33(3): 676-682. DOI: 10.2337/dc09-1848. PubMed DOI

Miyoshi T, Onoue G, Hirohata A, Hirohata S, Usui S, Hina K, et al. (2010). Serum adipocyte fatty acid-binding protein is independently associated with coronary atherosclerotic burden measured by intravascular ultrasound. Atherosclerosis 211: 164-169. DOI: 10.1016/j.atherosclerosis.2010.01.032. PubMed DOI

Murahovschi V, Pivovarova O, Ilkavets I, Dmitrieva RM, Döcke S, Keyhani-Nejad F, et al. (2015). WISP1 is a novel adipokine linked to inflammation in obesity. Diabetes 64: 856-866. DOI: 10.2337/db14-0444. PubMed DOI

Novotny D, Vaverkova H, Karasek D, Lukes J, Slavik L, Malina P, Orsag J (2014). Evaluation of total adiponectin, adipocyte fatty acid binding protein and fibroblast growth factor 21 levels in individuals with metabolic syndrome. Physiol Res 63: 219-228. PubMed DOI

Ohkura T, Shiochi H, Fujioka Y, Sumi K, Yamamoto N, Matsuzawa K, et al. (2013). 20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report. Cardiovasc Diabetol 12: 21. DOI: 10.1186/1475-2840-12-21. PubMed DOI

Okura T, Nakamura R, Fujioka Y, Kawamoto-Kitao S, Ito Y, Matsumoto K, et al. (2018). CPR-IR is an insulin resistance index that is minimally affected by hepatic insulin clearance-A preliminary research. PLoS One 13, e0197663. DOI: 10.1371/journal.pone.0197663. PubMed DOI

Ortega-Senovilla H, Schaefer-Graf U, Meitzner K, Abou-Dakn M, Graf K, Kintscher U, Herrera E (2011). Gestational diabetes mellitus causes changes in the concentrations of adipocyte fatty acid-binding protein and other adipocytokines in cord blood. Diabetes Care 34: 2061-2066. DOI: 10.2337/dc11-0715. PubMed DOI

Powe CE, Allard C, Battista MC, Doyon M, Bouchard L, Ecker JL, et al. (2016). Heterogeneous Contribution of Insulin Sensitivity and Secretion Defects to Gestational Diabetes Mellitus. Diabetes Care 39: 1052-1055. DOI: 10.2337/dc15-2672. PubMed DOI

Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B (2010). Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia 53: 268-276. DOI: 10.1007/s00125-009-1600-8. PubMed DOI

Ryckman KK, Spracklen CN, Smith CJ, Robinson JG, Saftlas AF (2015). Maternal lipid levels during pregnancy and gestational diabetes: a systematic review and meta-analysis. BJOG 122: 643-651. DOI: 10.1111/1471-0528.13261. PubMed DOI

Sahin Ersoy G, Altun Ensari T, Subas S, Giray B, Simsek EE, Cevik O (2017). WISP1 is a novel adipokine linked to metabolic parameters in gestational diabetes mellitus. J Matern Fetal Neonatal Med 30: 942-946. DOI: 10.1080/14767058.2016.1192118. PubMed DOI

Šimják P, Cinkajzlová A, Anderlová K, Pařízek A, Mráz M, Kršek M, Haluzík M (2018). The role of obesity and adipose tissue dysfunction in gestational diabetes mellitus. J Endocrinol 238: R63-R77. DOI: 10.1530/JOE-18-0032. PubMed DOI

Spurná J, Karásek D, Kubíčková V, Goldmannová D, Krystyník O, Schovánek J, Zadražil J (2018). Relationship of Selected Adipokines with Markers of Vascular Damage in Patients with Type 2 Diabetes. Metab Syndr Relat Disord 16: 246-253. DOI: 10.1089/met.2017.0179. PubMed DOI

Williams H, Mill CA, Monk BA, Hulin-Curtis S, Johnson JL, George SJ (2016). Wnt2 and WISP-1/CCN4 Induce Intimal Thickening via Promotion of Smooth Muscle Cell Migration. Arterioscler Thromb Vasc Biol 36: 1417-1424. DOI: 10.1161/ATVBAHA.116.307626. PubMed DOI

Wright LH, Herr DJ, Brown SS, Kasiganesan H, Menick DR (2018). Angiokine Wisp-1 is increased in myocardial infarction and regulates cardiac endothelial signaling. JCI Insight 3(4): 95824. DOI: 10.1172/jci.insight.95824. PubMed DOI

Xu A, Vanhoutte PM (2012). Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease. Am J Physiol Heart Circ Physiol 302: H1231-H1240. DOI: 10.1152/ajpheart.00765.2011. PubMed DOI

Yanai H, Yoshida H (2019). Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives. Int J Mol Sci 20(5): E1190. DOI: 10.3390/ijms20051190. PubMed DOI

Yaribeygi H, Atkin SL, Sahebkar A (2019). Wingless-type inducible signaling pathway protein-1 (WISP1) adipokine and glucose homeostasis. J Cell Physiol 234: 16966-16970. DOI: 10.1002/jcp.28412. PubMed DOI

Zhang Y, Zhang HH, Lu JH, Zheng SY, Long T, Li YT, Wu WZ, Wang F (2016). Changes in serum adipocyte fatty acid-binding protein in women with gestational diabetes mellitus and normal pregnant women during mid- and late pregnancy. J Diabetes Investig 7: 797-804. DOI: 10.1111/jdi.12484. PubMed DOI

Adiponectin, A-FABP and FGF-19 Levels in Women with Early Diagnosed Gestational Diabetes

Adipocytokines in Graves' orbitopathy and the effect of high-dose corticosteroids